Published
Risk Factors on Covid-19 Drugs
Published in August 2024 Issue 08 (Vol. 12, Issue 8, 2024)

Abstract
ABSTRACTTo increase the success in Covid 19 treatment, many drug suggestions are presented, and some clinical studies to are shared in the literature. There have been some attempts to use some of these drugs in combination. However, using more than one drug together may cause serious side effects on patients. Therefore, detecting drug-drug interactions of the drugs used will be of great importance in the treatment of Covid 19. In this study, the interactions of 8 drugs used for Covid 19 treatment with 645 different drugs and possible side effects estimates have been produced using Graph Convolutional Networks. As a result of the experiments, it has been found that the hematopoietic system and the cardiovascular system are exposed to more side effects than other organs. Among the focused drugs, Heparin and Atazanavir appear to cause more adverse reactions than other drugs. In addition, as it is known that some of these 8 drugs are used together in Covid-19 treatment, the side effects caused by using these drugs together are shared. With the experimental result obtained, it is aimed to facilitate the selection of the drugs and increase the success of Covid 19 treatment according to the targeted patient. In this review, we conclude some AEs of vitamin-D, zinc, Remdesivir, Hydroxychloroquine or chloroquine, azithromycin, dexamethasone, amantadine, aspirin reported in different papers and we continue the rest of the drugs in second part of our review article. Keywords: Mechanism, Treatment, Side effects of covid -19 drugs
Authors (5)
Kunchala Malleswari
View all publications →Desireddy.Rama Bramha Reddy
View all publications →Mogilli.Lakshmi Parvathi
View all publications →Gangavarapu Sowmya Sri
View all publications →Pichuka Harika
View all publications →Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Article Information
Published in:
August 2024 Issue 08 (Vol. 12, Issue 8, 2024)AJPHR1208001
AJPHR-1208001
2024-08-01
Article Impact
Views:5,069
Downloads:1,668
scite_
Smart Citations
0Citing Publications
0Supporting
0Mentioning
0Contrasting
View Citations
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
How to Cite
Malleswari & Bramha, D. & Parvathi & Sowmya, G. & Harika (2024). Risk Factors on Covid-19 Drugs. American Journal of Pharmacy and Health Research, 12(8), xx-xx. DOI:https://doi.org/10.5281/zenodo.13833439

